No profile data available.
Fortress Biotech, Inc. (FBIO) is a healthcare company in the skin treatment pharmaceuticals industry, based in Bay Harbor Islands, United States, with about 78 full-time employees.
It reported revenue of $63.26 million for fiscal year 2025, up 9.7% from fiscal year 2024, and net income of -$1.88 million. Its largest business segment, Journey, brought in 98% of segment revenue in fiscal year 2025. Its market capitalization was $71.20 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally.
Fortress Biotech reported $63.26 million in revenue for fiscal year 2025, up 9.7% from $57.68 million in fiscal year 2024.
Journey, with $61.86 million or 98% of segment revenue in fiscal year 2025. Next: Avenue (2%).
$71.20 million as of October 9, 2026.
Listed companies of a similar size in the same industry (skin treatment pharmaceuticals) include Q32 Bio Inc. (QTTB), Sol-Gel Technologies Ltd. (SLGL), Journey Medical Corporation (DERM), Quoin Pharmaceuticals, Ltd. (QNRX).